Efpeglenatide
AMPLITUDE-L
Sanofi · Phase 3 · Terminated · Enrollment 370
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | T2D only | n/r | 56 | n/r | n/r |
| Efpeglenatide 2 mg | T2D only | 2 mg | 56 | n/r | n/r |
| Efpeglenatide 4 mg | T2D only | 4 mg | 56 | n/r | n/r |
| Efpeglenatide 6 mg | T2D only | 6 mg | 56 | n/r | n/r |